Evidence map›Paper›PMID 28231258›Full record

ArticlePloS one2017

Depressive symptoms in HIV-infected and seronegative control subjects in Cameroon: Effect of age, education and gender.

Georgette D Kanmogne, Fang Qiu, Félicien E Ntone, Julius Y Fonsah, Dora M Njamnshi, Callixte T Kuate, Roland F Doh, Anne M Kengne, Claude T Tagny, Emilienne Nchindap and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Georgette D KanmogneDepartment of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Fang QiuDepartment of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Félicien E NtoneFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Julius Y FonsahFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Dora M NjamnshiHIV-Day Care Service, Yaoundé Central Hospital, Yaoundé, Cameroon.
Callixte T KuateFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Roland F DohDepartment of Neurology, Yaoundé Central Hospital, Yaoundé, Cameroon.
Anne M KengneDepartment of Neurology, Yaoundé Central Hospital, Yaoundé, Cameroon.
Claude T TagnyFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Emilienne NchindapYaoundé University Teaching Hospital, Yaoundé, Cameroon.
Léopoldine KenmogneYaoundé University Teaching Hospital, Yaoundé, Cameroon.
Dora MbanyaFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Mariana ChernerHIV Neurobehavioral Research Center, School of Medicine, University of California San Diego, San Diego, California, United States of America.
Robert K HeatonDepartment of Psychiatry, School of Medicine, University of California San Diego, La Jolla, San Diego, California, United States of America.
Alfred K NjamnshiFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Université de Yaoundé I · CMCentral Hospital of Yaoundé · CMUniversity of Nebraska Medical Center · USUniversity Teaching Hospital of Yaounde · CMNeurobehavioral Research (United States) · USUniversity of California, San Diego · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
HIV Genetic Diversity and Viral NeuropathogenesisR01MH094160 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI KANMOGNE, GEORGETTE D. · 2012 to 2016
$3.1M
NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH094160
6 · The paper itself

Abstract

Depression is a leading cause of HIV/AIDS disease burden; it worsens health outcomes and quality of life. Addressing this problem requires accurate quantification of the extra burden of depression to HIV/AIDS in a given population, and knowledge of the baseline depression prevalence in the general population. There has been no previous study of depression in the general Cameroonian population. The current study attempts to address that important need. We used the Beck Depression Inventory-II to assess the prevalence and severity of depressive symptoms in 270 HIV-infected and seronegative Cameroonians. Univariate analyses showed a trend toward higher depressive symptoms among cases, compared to controls (p = 0.055), and among older subjects (>40 years), compared to younger subjects (≤40 years) (p = 0.059). Analysis of depression severity showed that 33.73% of cases had moderate-to-severe depressive symptoms, compared to 19.8% of controls (p<0.01). However, multivariable negative binomial regression analyses showed no effect of age, HIV status, CD4 levels, viral loads, ART, or opportunistic infections on the risk of depressive symptoms. Both univariate and multivariable regression analyses showed significantly higher risk of depressive symptoms among females compared to males; this was significant for both female controls and female cases. Female cases had significantly higher CD4 cell counts and lower viral loads, compared to males. Both univariate and multivariable regression analyses showed that lower education (≤10 years) was associated with increased risk of depressive symptoms. This study shows a high prevalence of depressive symptoms among seronegative controls and HIV-infected Cameroonians. Integrating care for mental disorders such as depression into primary health care and existing HIV/AIDS treatment programs in Cameroon may improve the wellbeing of the general population and could lower the HIV/AIDS burden.

Indexed as

AdultAge FactorsCameroonCross-Sectional StudiesDepressionDepressive DisorderEducational StatusFemaleHIVHIV InfectionsHumansMaleMiddle AgedRisk FactorsSex FactorsViral Load

Identifiers

PMID28231258
PMCPMC5322951
OpenAlexW2590597395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.